Journal Mobile Options
Table of Contents
Vol. 34, No. 4, 2011
Issue release date: June 2011
Section title: Paper

Temporary free access
Part of the Karger in focus:Personalized Medicine collection
Kidney Blood Press Res 2011;34:291–298
(DOI:10.1159/000326895)

Molecular Phenotypes of Kidney Graft Rejection

Hribova P.a · Viklicky O.a, b
aTransplant Laboratory and bDepartment of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
email Corresponding Author

Prof. Ondrej Viklicky, MD, PhD

Department of Nephrology, Institute for Clinical and Experimental Medicine

Videnska 1958/9

CZ–140 21 Prague 4 (Czech Republic)

Tel. +420 26136 4106, E-Mail ondrej.viklicky@ikem.cz


References

  1. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, Baldwin W, Banfi G, Collins AB, et al: Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008;8:753–760.
  2. Misra RR, Pinsky PF, Srivastava S: Prognostic factors for hematologic cancers. Hematol Oncol Clin North Am 2000;14:907–924.
  3. Rudnicki M, Perco P, Enrich J, Eder S, Heininger D, Bernthaler A, Wiesinger M, Sarkozi R, Noppert SJ, Schramek H, et al: Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease. Lab Invest 2009;89:337–346.
  4. Brabcova I, Tesar V, Honsova E, Lodererova A, Novotna E, Maixnerova D, Merta M, Burgelova M, Hribova P, Skibova J, et al: Association of advanced vasculopathy and transforming growth factor-beta1 gene expression with immunoglobulin A nephropathy progression. Nephrol Dial Transplant 2011;26:573–579.
  5. Edemir B, Kurian SM, Eisenacher M, Lang D, Muller-Tidow C, Gabriels G, Salomon DR, Schlatter E: Activation of counter-regulatory mechanisms in a rat renal acute rejection model. BMC Genomics 2008;9:71.
  6. Halloran PF, de Freitas DG, Einecke G, Famulski KS, Hidalgo LG, Mengel M, Reeve J, Sellares J, Sis B: The molecular phenotype of kidney transplants. Am J Transplant 2010;10:2215–2222.
  7. Famulski KS, Sis B, Billesberger L, Halloran PF: Interferon-gamma and donor MHC class I control alternative macrophage activation and activin expression in rejecting kidney allografts: a shift in the Th1-Th2 paradigm. Am J Transplant 2008;8:547–556.
  8. Famulski KS, Broderick G, Einecke G, Hay K, Cruz J, Sis B, Mengel M, Halloran PF: Transcriptome analysis reveals heterogeneity in the injury response of kidney transplants. Am J Transplant 2007;7:2483–2495.
  9. Hoffmann SC, Hale DA, Kleiner DE, Mannon RB, Kampen RL, Jacobson LM, Cendales LC, Swanson SJ, Becker BN, Kirk AD: Functionally significant renal allograft rejection is defined by transcriptional criteria. Am J Transplant 2005;5:573–581.
  10. Li B, Hartono C, Ding R, Sharma VK, Ramaswamy R, Qian B, Serur D, Mouradian J, Schwartz JE, Suthanthiran M: Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001;344:947–954.
  11. Sawitzki B, Bushell A, Steger U, Jones N, Risch K, Siepert A, Lehmann M, Schmitt-Knosalla I, Vogt K, Gebuhr I, et al: Identification of gene markers for the prediction of allograft rejection or permanent acceptance. Am J Transplant 2007;7:1091–1102.
  12. Mueller TF, Reeve J, Jhangri GS, Mengel M, Jacaj Z, Cairo L, Obeidat M, Todd G, Moore R, Famulski KS, et al: The transcriptome of the implant biopsy identifies donor kidneys at increased risk of delayed graft function. Am J Transplant 2008;8:78–85.
  13. Avihingsanon Y, Ma N, Pavlakis M, Chon WJ, Uknis ME, Monaco AP, Ferran C, Stillman I, Schachter AD, Mottley C, et al: On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes. J Am Soc Nephrol 2005;16:1542–1548.
  14. Bodonyi-Kovacs G, Putheti P, Marino M, Avihingsanon Y, Uknis ME, Monaco AP, Strom TB, Pavlakis M: Gene expression profiling of the donor kidney at the time of transplantation predicts clinical outcomes 2 years after transplantation. Hum Immunol 2010;71:451–455.
  15. Perco P, Kainz A, Wilflingseder J, Soleiman A, Mayer B, Oberbauer R: Histogenomics: association of gene expression patterns with histological parameters in kidney biopsies. Transplantation 2009;87:290–295.
  16. Nickel P, Lacha J, Ode-Hakim S, Sawitzki B, Babel N, Frei U, Volk HD, Reinke P: Cytotoxic effector molecule gene expression in acute renal allograft rejection: correlation with clinical outcome; histopathology and function of the allograft. Transplantation 2001;72:1158–1160.
  17. Desvaux D, Schwarzinger M, Pastural M, Baron C, Abtahi M, Berrehar F, Lim A, Lang P, le Gouvello S: Molecular diagnosis of renal-allograft rejection: correlation with histopathologic evaluation and antirejection-therapy resistance. Transplantation 2004;78:647–653.
  18. Seiler M, Brabcova I, Viklicky O, Hribova P, Rosenberger C, Pratschke J, Lodererova A, Matz M, Schonemann C, Reinke P, et al: Heightened expression of the cytotoxicity receptor NKG2D correlates with acute and chronic nephropathy after kidney transplantation. Am J Transplant 2007;7:423–433.
  19. Sarwal M, Chua MS, Kambham N, Hsieh SC, Satterwhite T, Masek M, Salvatierra O Jr: Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003;349:125–138.
  20. Tsai EW, Rianthavorn P, Gjertson DW, Wallace WD, Reed EF, Ettenger RB: CD20+ lymphocytes in renal allografts are associated with poor graft survival in pediatric patients. Transplantation 2006;82:1769–1773.
  21. Bagnasco SM, Tsai W, Rahman MH, Kraus ES, Barisoni L, Vega R, Racusen LC, Haas M, Mohammed BS, Zachary AA, Montgomery RA: CD20-positive infiltrates in renal allograft biopsies with acute cellular rejection are not associated with worse graft survival. Am J Transplant 2007;7:1968–1973.
  22. Viklicky O, Hribova P, Volk HD, Slatinska J, Petrasek J, Bandur S, Honsova E, Reinke P: Molecular phenotypes of acute rejection predict kidney graft prognosis. J Am Soc Nephrol 2010;21:173–180.
  23. Sagoo P, Perucha E, Sawitzki B, Tomiuk S, Stephens DA, Miqueu P, Chapman S, Craciun L, Sergeant R, Brouard S, et al: Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest 2010;120:1848–1861.
  24. Newell KA, Asare A, Kirk AD, Gisler TD, Bourcier K, Suthanthiran M, Burlingham WJ, Marks WH, Sanz I, Lechler RI, et al: Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010;120:1836–1847.
  25. Zarkhin V, Chalasani G, Sarwal MM: The yin and yang of B cells in graft rejection and tolerance. Transplant Rev (Orlando) 2010;24:67–78.
    External Resources
  26. Bestard O, Cruzado JM, Rama I, Torras J, Goma M, Seron D, Moreso F, Gil-Vernet S, Grinyo JM: Presence of FoxP3+ regulatory T cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol 2008;19:2020–2026.
  27. Bunnag S, Allanach K, Jhangri GS, Sis B, Einecke G, Mengel M, Mueller TF, Halloran PF: FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. Am J Transplant 2008;8:1423–1433.
  28. Anglicheau D, Sharma VK, Ding R, Hummel A, Snopkowski C, Dadhania D, Seshan SV, Suthanthiran M: MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci USA 2009;106:5330–5335.
  29. Anglicheau D, Muthukumar T, Suthanthiran M: MicroRNAs: small RNAs with big effects. Transplantation 2010;90:105–112.
  30. Mengel M, Chang J, Kayser D, Gwinner W, Schwarz A, Einecke G, Broecker V, Famulski K, De Freitas DG, Guembes-Hidalgo L, et al: The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course. Am J Transplant 2010, E-pub ahead of print.
  31. Matl I, Hribova P, Honsova E, Brabcova I, Viklicky O: Potential predictive markers in protocol biopsies for premature renal graft loss. Kidney Blood Press Res 2010;33:7–14.
  32. Scherer A, Krause A, Walker JR, Korn A, Niese D, Raulf F: Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies. Transplantation 2003;75:1323–1330.
  33. Park WD, Griffin MD, Cornell LD, Cosio FG, Stegall MD: Fibrosis with inflammation at one year predicts transplant functional decline. J Am Soc Nephrol 2010;21:1987–1997.
  34. Pribylova-Hribova P, Kotsch K, Lodererova A, Viklicky O, Vitko S, Volk HD, Lacha J: TGF-beta1 mRNA upregulation influences chronic renal allograft dysfunction. Kidney Int 2006;69:1872–1879.
  35. Hribova P, Lacha J, Kotsch K, Volk HD, Brabcova I, Skibova J, Vitko S, Viklicky O: Intrarenal cytokine and chemokine gene expression and kidney graft outcome. Kidney Blood Press Res 2007;30:273–282.
  36. Einecke G, Reeve J, Sis B, Mengel M, Hidalgo L, Famulski KS, Matas A, Kasiske B, Kaplan B, Halloran PF: A molecular classifier for predicting future graft loss in late kidney transplant biopsies. J Clin Invest 2010;120:1862–1872.
  37. Famulski KS, Einecke G, Sis B, Mengel M, Hidalgo LG, Kaplan B, Halloran PF: Defining the canonical form of T-cell-mediated rejection in human kidney transplants. Am J Transplant 2010;10:810–820.
  38. Sis B, Halloran PF: Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection. Curr Opin Organ Transplant 2010;15:42–48.
  39. Sis B, Mengel M, Haas M, Colvin RB, Halloran PF, Racusen LC, Solez K, Baldwin WM 3rd, Bracamonte ER, Broecker V, et al: Banff ‘09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010;10:464–471.
  40. Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF: Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009;9:2312–2323.
  41. Muthukumar T, Dadhania D, Ding R, Snopkowski C, Naqvi R, Lee JB, Hartono C, Li B, Sharma VK, Seshan SV, et al: Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005;353:2342–2351.
  42. Matz M, Beyer J, Wunsch D, Mashreghi MF, Seiler M, Pratschke J, Babel N, Volk HD, Reinke P, Kotsch K: Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function. Kidney Int 2006;69:1683–1690.
  43. Afaneh C, Muthukumar T, Lubetzky M, Ding R, Snopkowski C, Sharma VK, Seshan S, Dadhania D, Schwartz JE, Suthanthiran M: Urinary cell levels of mRNA for OX40, OX40L, PD-1, PD-L1, or PD-L2 and acute rejection of human renal allografts. Transplantation 2010;90:1381–1387.
  44. O’Riordan E, Orlova TN, Mei JJ, Butt K, Chander PM, Rahman S, Mya M, Hu R, Momin J, Eng EW, et al: Bioinformatic analysis of the urine proteome of acute allograft rejection. J Am Soc Nephrol 2004;15:3240–3248.
  45. Schaub S, Rush D, Wilkins J, Gibson IW, Weiler T, Sangster K, Nicolle L, Karpinski M, Jeffery J, Nickerson P: Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol 2004;15:219–227.
  46. Wittke S, Haubitz M, Walden M, Rohde F, Schwarz A, Mengel M, Mischak H, Haller H, Gwinner W: Detection of acute tubulointerstitial rejection by proteomic analysis of urinary samples in renal transplant recipients. Am J Transplant 2005;5:2479–2488.
  47. O’Riordan E, Orlova TN, Mendelev N, Patschan D, Kemp R, Chander PN, Hu R, Hao G, Gross SS, Iozzo RV, et al: Urinary proteomic analysis of chronic allograft nephropathy. Proteomics Clin Appl 2008;2:1025–1035.
  48. Quintana LF, Sole-Gonzalez A, Kalko SG, Banon-Maneus E, Sole M, Diekmann F, Gutierrez-Dalmau A, Abian J, Campistol JM: Urine proteomics to detect biomarkers for chronic allograft dysfunction. J Am Soc Nephrol 2009;20:428–435.